TAMOXIFEN THERAPY IN PRIMARY BREAST-CANCER - BIOLOGY, EFFICACY, AND SIDE-EFFECTS

被引：165
作者：
LOVE, RR
机构：
[1] UNIV WISCONSIN,CTR CLIN CANC,DEPT HUMAN ONCOL,MADISON,WI 53706
[2] UNIV WISCONSIN,CTR CLIN CANC,CANC PREVENT PROGRAM,MADISON,WI 53706
[3] UNIV WISCONSIN,CTR CLIN CANC,BREAST PROGRAM,MADISON,WI 53706
来源：
JOURNAL OF CLINICAL ONCOLOGY | 1989年 / 7卷 / 06期
关键词：
D O I：
10.1200/JCO.1989.7.6.803
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：803 / 815
页数：13
相关论文
共 121 条
[1]  
ASHFORD AR, 1988, CANCER, V61, P33, DOI 10.1002/1097-0142(19880101)61:1<33::AID-CNCR2820610107>3.0.CO
[2]  
2-I
[3]  
AUGER MJ, 1988, CANCER, V61, P1316, DOI 10.1002/1097-0142(19880401)61:7<1316::AID-CNCR2820610707>3.0.CO
[4]  
2-5
[5]  
BENRY J, 1987, EUR J CANCE CLIN ONC, V23, P517
[6]  
BIANCO AR, 1985, REV ENDO REL CANCE S, V17, P123
[7]  
BRUM LD, 1986, CANCER, V57, P2123
[8]  
BRUNNERT K, 1985, REV ENDOCRINE RELA S, V17, P99
[9]   ESTROGEN USE AND ALL-CAUSE MORTALITY - PRELIMINARY-RESULTS FROM THE LIPID RESEARCH CLINICS PROGRAM FOLLOW-UP-STUDY [J].
BUSH, TL ;
COWAN, LD ;
BARRETTCONNOR, E ;
CRIQUI, MH ;
KARON, JM ;
WALLACE, RB ;
TYROLER, HA ;
RIFKIND, BM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1983, 249 (07) :903-906
[10]  
CAFFIER H, 1985, REV ENDOCRINE RELA S, V17, P103
12345678910